TCI Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

TCI Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-666	Closed	-$7.39K	–	947
2023 Q1	$7.39K	Sell	666 -371	-36%	-$4.57K	﹤0.01%	1270
2022 Q4	$12.7K	Buy	1,037 +371	+56%	+$4.18K	﹤0.01%	913
2022 Q3	$7K	Hold	666	–	–	﹤0.01%	1246
2022 Q2	$7K	Buy	666 +37	+6%	+$305	﹤0.01%	1237
2022 Q1	$6K	Buy	+629	New	+$5.9K	﹤0.01%	1416
2021 Q4	–	Sell	-522	Closed	-$5K	–	2356
2021 Q3	$5K	Sell	522 -84	-14%	-$859	﹤0.01%	1586
2021 Q2	$6K	Buy	+606	New	+$5.92K	﹤0.01%	1309

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

TCI Wealth Advisors's FOLD Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2023, closing a stake of 666 shares — an estimated $7.39K sold.

TCI Wealth Advisors first reported a position in FOLD in Q2 2021 and held it in 7 quarters. The position peaked at $12.7K in Q4 2022. 216 funds tracked by Wall St. Rank hold FOLD as of Q2 2023.

TCI Wealth Advisors reported no remaining Amicus Therapeutics position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 666 Amicus Therapeutics shares in Q2 2023, an estimated $7.39K.
TCI Wealth Advisors first reported a position in Amicus Therapeutics in Q2 2021 and held it in 7 quarters.
TCI Wealth Advisors's Amicus Therapeutics position peaked at $12.7K in Q4 2022.
216 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.